Free HR Services from our Employee Relations Experts. Find out more.

Our Business Services

Chamber of Commerce & Industry WA

With over 130 years of experience representing WA businesses, we’re ready to help with the resources and advice you need to succeed.

Employee Relations Helpline

Employee Relations Helpline

Get timely, reliable and practical employee relations advice on employment laws, the awards system and other human resource matters. CCIWA Members get unlimited access.

Legal Services

Legal Services

Our team of experienced, client-focused business lawyers offer a full range of Commercial Law & Employment Law services for all your essential legal needs.

Accounting & Taxation Services

Optima Partners and CCIWA

Innovative and personalised accounting, taxation and business advisory services that focus on delivering the best results to help your business grow.

Workplace Health & Safety Services

Workplace Health & Safety Services

Unlock the potential of your business with our suite of staff training and development programs, crafted by workplace relations experts and tailored to your business needs.

Construction & Mining IR Services

Construction & Mining IR Services

We offer extensive, independent and practical industrial and labour relations support to the engineering, construction and mining industries.

Workplace Training & Development

Workplace Training & Development

Unlock the potential of your business with our suite of staff training and development programs, crafted by workplace relations experts and tailored to your business needs.

Apprenticeship Support Australia WA

Apprenticeship Support Australia WA

Our dedicated team specialises in assisting employers maximise the benefits of investing in apprenticeships and traineeships to build local skills for the diverse WA workforce. Our team of experts will provide all the advice, support and services you need — free of charge.

Work Integrated Learning – Internships

Work Integrated Learning - Internships

Tap into WA’s future workforce with our Work Integrated Learning – Internships program. This free service facilitates university student work experience placements for your business.

Industry Capability Network WA

Industry Capability Network WA

Connecting your business with mining, construction, infrastructure, defence and other major projects using the ICN Gateway.

International Trade Services

International Trade Services

Take your business global using our comprehensive suite of international trade services to streamline importing and exporting, reduce risks and identify international partners.


New frontier in brain injury treatment

By Beatrice Thomas

A Perth biotech is hoping to revolutionise how acute brain injuries are treated globally, with a breakthrough drug that can protect brain cells at the time of injury. 

Argenica Therapeutics, which was spun out of the Perron Institute for Neurological and Translational Science and the University of Western Australia, is developing a neuroprotective therapeutic that has the potential to reduce brain damage after stroke, concussion and other brain injuries. 

“Currently, the only drug therapeutic available to stroke patients is a drug that dissolves the clot that has caused a stroke; there are no drugs on the market that are able to protect brain cells from dying following a stroke,” says Argenica Therapeutics CEO Liz Dallimore. 

“Our mission at Argenica is to help people who have suffered neurological injuries by protecting brain cells at the time of injury, giving them a greater chance of functional recovery after injury and a better quality of life.” 

brain injury

A decade of research 

Dr Dallimore says Argenica was incorporated in 2019 following a decade of research at the Perron Institute. 

“Whilst we're a relatively new company, we are backed by a huge amount of preclinical research that's happened right here in Western Australia,” she adds. 

Argenica listed on the ASX in June 2021 following a $7 million capital raise to support human clinical trials for its lead neuroprotective peptide ARG-007 in the next step towards commercialisation. 

It currently plans to begin a Phase 1 trial, which involves testing the drug in healthy volunteers, to be initiated towards the end of the year with the data used to progress to a Phase 2 trial in stroke patients.

Perron Institute Senior Research Scientist Bruno Meloni says one of the major difficulties during the early phase of research and development is attracting funding, which slows down the research. 

"It’s always been very difficult due to the competitive nature of obtaining research funding,” Professor Meloni says. 

“And in particular, the area that we've been working in, which is neuroprotection, whilst addressing a huge unmet need in stroke care, has been very difficult because big pharma and other scientists have recognised the difficulty to find a drug that is neuroprotective and can be effective after stroke.” 

‘Have faith in the research’ 

Professor Meloni’s message to the business community is clear: “Have faith in the research and the scientists doing the work and, if possible, try and provide funding to progress the development of the work.” 

Dr Dallimore says she views Argenica’s membership with CCIWA as a partnership to help advocate for WA’s world-class life sciences sector. 

“We’ve got world-class research institutes like the Perron Institute, fantastic science going on here and some amazing emerging companies coming out of WA,” she says.

Dr Dallimore says within three years the company hopes to be entering a larger-scale Phase 3 clinical trial in stroke patients as well as exploring other types of brain injuries including traumatic brain injury, concussions, and perinatal hypoxia where babies suffer stroke during birth. 

“We’ve got some really exciting stuff coming up; in three years, there’ll be a lot happening,” she says. 

CCIWA is a passionate advocate for Perth’s burgeoning tech sector. 

To be part of WA’s peak business organisation, get in touch via 1300 422 492 or [email protected]. 

Tagged under: